Home/Gallop Oncology/Joseph Jurcic, MD

JJ

Joseph Jurcic, MD

Scientific Advisory Board Member

Gallop Oncology

Therapeutic Areas

Oncology Hematologic Malignancies Solid Tumors

Gallop Oncology Pipeline

Drug	Indication	Phase
LYT-200	Relapsed/Refractory Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS)	Phase 1/2

Leadership Team at Gallop Oncology

Steven Rosen, MD

Scientific Advisory Board Member

Eytan Stein, MD

Scientific Advisory Board Member

David Sidransky, MD

Scientific Advisory Board Member

View full Gallop Oncology profile